Friday, November 17, 2017 7:54:52 PM
We are where we are as we have phase 1 numbers period. Our biggest trial is with 20 humans. What big pharma is going to agree on a licensing agreement on Pluristem's terms without significant stats on a significant population. Sure they will throw cash as some, but not likely what the twins are asking. Just because they're phase 3, doesn't mean jack right now. They're really not a phase 3 company by normal measures. Really think about it honestly and you may see the light like I did.
Having good results from a trial with actual phase 2 enrolment numbers would change that. If I/C numbers are good, then maybe we will see a partnership with teeth. Unfortunately we have to wait until April.
FEATURED Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM
Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • BLEG • Apr 16, 2024 8:30 AM
Avant Technologies Begins Development on Next-Generation AI-Driven Resource Allocation Solution • AVAI • Apr 16, 2024 8:00 AM
UC Asset Expected to Report $0.03/share Net Profit for 2023 • UCASU • Apr 11, 2024 10:00 AM
Kona Gold Beverages & Apple Rush Co. Execute Joint Venture & Manufacturing Agreement • APRU • Apr 11, 2024 9:40 AM